Literature DB >> 226468

On the genetics of the human serum paraoxonase (EC 3.1.1.2).

M Geldmacher-v Mallinckrodt, G Hommel, J Dumbach.   

Abstract

Incubation of the sera of 799 nonrelated persons with paraoxon led to varying degrees of inhibition of the serum cholinesterase (EC 3.1.1.8) with residual activity between 0% and 67.4% of the initial activity. This is the result of a differing paraoxonase (EC 3.1.1.2) activity. The residual activities show a trimodal distribution. The results of studies of 99 families with children show that an autosomal dominant herdity factor is most likely. Consideration of the constellations of the activity values within the families can thus yield a stochastic external criterion. This, together with the shape of the distribution of the individual values, gives good statistical estimates for the distributions and frequencies of the three groups obtained by an iteration technique. Tests of association that take account of group membership show that residual activity does not depend on the blood groups A, B, O, and Rh, or on age. A conclusive argument for our assumption of three activity groups is that the resulting group frequencies are consistent with the Hardy-Weinberg rule.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 226468     DOI: 10.1007/bf00399398

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  9 in total

1.  Genetic polymorphism and interethnic variability of plasma paroxonase activity.

Authors:  J R Playfer; L C Eze; M F Bullen; D A Evans
Journal:  J Med Genet       Date:  1976-10       Impact factor: 6.318

2.  Organophosphate splitting serum enzymes in different mammals.

Authors:  R Zech; K Zürcher
Journal:  Comp Biochem Physiol B       Date:  1974-07-15

3.  [Substrate specificity and the stability of a phosphoryl phosphatase from rabbit serum].

Authors:  R Zech; K Zürcher
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1973-05

4.  [Genetically determined polymorphism of human serum paraoxonase (EC 3.1.1.2)].

Authors:  H H Lindorf; M Petenyi; M Flügel; T Fischer; T Hiller
Journal:  Humangenetik       Date:  1973

5.  [Letter: Comments in response to genetically determined polymorphism of human serum paraxonase (EC 3.1.1.2) (author's transl)].

Authors:  H H Lindorf; M Petenyi; M Flügel; T Fischer; T Hiller
Journal:  Humangenetik       Date:  1973-09-20

6.  [Correlation between the observed variations in the inhibition of serum cholinesterase by E 600 and the activity of the enzyme system from human serum which cleaves E 600].

Authors:  W Baumgartner; M Pétenyi; H Burgis; H H Lindorf; H Metzner
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1972-02

7.  [Enzymatic hydrolysis of diethyl-p-nitrophenylphosphate (E 600) by human serum].

Authors:  K Krisch
Journal:  Z Klin Chem Klin Biochem       Date:  1968-01

8.  [Differences in the reaction of human serum cholinesterases with E 600 (0,0-diethyl-0-(p-nitrophenyl)-phosphate)].

Authors:  U Rabast; H H Lindorf
Journal:  Arch Toxikol       Date:  1969

9.  [Specific proof of alkyl phosphate poisoning (E 600, E 605, systox) in the blood and brain tissues with the aid of an enzyme-activating antidote (Pyridinealdoxime-methyl iodide, PAM)].

Authors:  K D FRIEDBERG; F SAKAI
Journal:  Dtsch Z Gesamte Gerichtl Med       Date:  1958
  9 in total
  9 in total

Review 1.  Pharmacogenetics and ecogenetics.

Authors:  D P Agarwal; H W Goedde
Journal:  Experientia       Date:  1986-10-15

2.  Genetics of plasma paroxonase activity.

Authors:  L Iselius; D A Evans; J R Playfer
Journal:  J Med Genet       Date:  1982-12       Impact factor: 6.318

3.  Paraoxon hydrolysis in human serum mediated by a genetically variable arylesterase and albumin.

Authors:  J Ortigoza-Ferado; R J Richter; S K Hornung; A G Motulsky; C E Furlong
Journal:  Am J Hum Genet       Date:  1984-03       Impact factor: 11.025

4.  The human serum paraoxonase/arylesterase polymorphism.

Authors:  H W Eckerson; C M Wyte; B N La Du
Journal:  Am J Hum Genet       Date:  1983-11       Impact factor: 11.025

5.  The human serum paraoxonase polymorphism: identification of phenotypes by their response to salts.

Authors:  H W Eckerson; J Romson; C Wyte; B N La Du
Journal:  Am J Hum Genet       Date:  1983-03       Impact factor: 11.025

6.  Plasma paraoxonase polymorphism: a new enzyme assay, population, family, biochemical, and linkage studies.

Authors:  R F Mueller; S Hornung; C E Furlong; J Anderson; E R Giblett; A G Motulsky
Journal:  Am J Hum Genet       Date:  1983-05       Impact factor: 11.025

7.  Effects of 5' regulatory-region polymorphisms on paraoxonase-gene (PON1) expression.

Authors:  V H Brophy; R L Jampsa; J B Clendenning; L A McKinstry; G P Jarvik; C E Furlong
Journal:  Am J Hum Genet       Date:  2001-05-02       Impact factor: 11.025

8.  Determinants of variation in human serum paraoxonase activity.

Authors:  D L Rainwater; S Rutherford; T D Dyer; E D Rainwater; S A Cole; J L Vandeberg; L Almasy; J Blangero; J W Maccluer; M C Mahaney
Journal:  Heredity (Edinb)       Date:  2008-10-29       Impact factor: 3.821

9.  Role of genetic polymorphism of human plasma paraoxonase/arylesterase in hydrolysis of the insecticide metabolites chlorpyrifos oxon and paraoxon.

Authors:  C E Furlong; R J Richter; S L Seidel; A G Motulsky
Journal:  Am J Hum Genet       Date:  1988-09       Impact factor: 11.025

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.